Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Tan

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Oncogenesis|April 5, 2013
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loopK E Ware, T K Hinz, E Kleczko, et al.
ESMO Open|July 22, 2022
Trials without borders-decentralized trials and ensuring access to novel cancer therapies during a global pandemicA C Tan, T J Y Tan, S P L Saw, et al.
Journal of Dental Research|March 8, 2018
GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell SystemsB K B Lee, C P Gan, J K Chang, et al.
British Journal of Cancer|July 29, 2010
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancerI Garrido-Laguna, A C Tan, M Uson, et al.
British Journal of Cancer|July 23, 2013
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant modelJ J Arcaroli, K S Quackenbush, A Purkey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerJ J Lin, S V Liu, C E McCoach, et al.
ESMO Open|June 25, 2023
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working groupH H Loong, T Shimizu, A Prawira, et al.
Oncogene|April 21, 2015
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancerJ J Morton, G Bird, S B Keysar, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 17, 2014
Dutch Chronic Pancreatitis Registry (CARE): design and rationale of a nationwide prospective evaluation and follow-upU Ahmed Ali, Y Issa, H van Goor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort studyM M Zheng, Y Xia, K Pan, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Oncogenesis|April 5, 2013
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loopK E Ware, T K Hinz, E Kleczko, et al.
ESMO Open|July 22, 2022
Trials without borders-decentralized trials and ensuring access to novel cancer therapies during a global pandemicA C Tan, T J Y Tan, S P L Saw, et al.
Journal of Dental Research|March 8, 2018
GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell SystemsB K B Lee, C P Gan, J K Chang, et al.
British Journal of Cancer|July 29, 2010
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancerI Garrido-Laguna, A C Tan, M Uson, et al.
British Journal of Cancer|July 23, 2013
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant modelJ J Arcaroli, K S Quackenbush, A Purkey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerJ J Lin, S V Liu, C E McCoach, et al.
ESMO Open|June 25, 2023
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working groupH H Loong, T Shimizu, A Prawira, et al.
Oncogene|April 21, 2015
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancerJ J Morton, G Bird, S B Keysar, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 17, 2014
Dutch Chronic Pancreatitis Registry (CARE): design and rationale of a nationwide prospective evaluation and follow-upU Ahmed Ali, Y Issa, H van Goor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort studyM M Zheng, Y Xia, K Pan, et al.
Pageof 7